To enable drug screening solutions that meet regulatory, operational, and enforcement standards.
SpectraCann is focused on developing drug screening solutions that align with real-world compliance needs, operational environments and evolving regulatory standards.
Our products are developed with regulatory requirements and enforcement standards in mind, ensuring screening solutions support consistent and defensible compliance decisions.
We collaborate with early pilot partners to rigorously test, refine, and validate our solutions within real-world operational environments.
SpectraCann is building a flexible platform designed to evolve with changing regulatory frameworks and future detection needs.
We develop technologies designed to support transparent, defensible compliance decisions.
Our work is grounded in rigorous science and engineering.
Our solutions are designed to perform consistently in real-world operational environments.
We develop and apply advanced detection technologies to solve emerging compliance challenges.
We design our solutions with the safety and operational needs of workplaces, public safety agencies, and communities at the forefront.
One of the most exciting moments of our journey to date is our participation in SLINGSHOT 2024, Asia’s leading deep-tech startup competition in Singapore. Competing alongside groundbreaking innovations and visionary entrepreneurs, this experience was a game-changer for SpectraCann.
SpectraCann is changing the on-site, rapid drug detection market with cutting-edge breathalyzers. Powered by optical physics quantum technology, their drug testing solution can detect multiple substances from a single breath sample, providing results in 30 seconds.
Amii is pleased to work with SpectraCann, a drug-detection technology company based in Edmonton. The project objective is to advance SpectraCann’s innovative detection technologies powered by quantum optics, leveraging Amii’s leading expertise and talent in artificial intelligence.
